1h Free Analyst Time
The herpes treatment market is forecast to grow by USD 1.14 billion during 2023-2028, accelerating at a CAGR of 4.43% during the forecast period. The report on the herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of herpes infection, large patient pool, and rising prevalence rate of shingles in older population.
The herpes treatment market is segmented as below:
By Product
- Vaccination
- Drug therapy
By Type
- Herpes zoster
- Herpes simplex
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the herpes treatment market covers the following areas:
- Herpes treatment market sizing
- Herpes treatment market forecast
- Herpes treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global herpes treatment market: AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., Bausch Health Companies Inc., CENTURION REMEDIES Pvt. Ltd., Cipla Inc., Eli Lilly and Co., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Zeelab Laboratories Ltd., and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of novel therapies."
According to the report, one of the major drivers for this market is the increasing prevalence of herpes infection.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AiCuris Anti infective Cures AG
- Aurobindo Pharma Ltd.
- Avet Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- CENTURION REMEDIES Pvt. Ltd.
- Cipla Inc.
- Eli Lilly and Co.
- Fresenius SE and Co. KGaA
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Maruho Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Zeelab Laboratories Ltd.
- Zydus Lifesciences Ltd.
